Page last updated: 2024-10-23

aspirin and Infections, Helicobacter

aspirin has been researched along with Infections, Helicobacter in 257 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

ExcerptRelevanceReference
"Peptic ulcers in patients receiving aspirin are associated with Helicobacter pylori infection."9.51Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. ( Avery, A; Coupland, CAC; Crooks, C; Dumbleton, J; Hawkey, C; Hobbs, FDR; Kendrick, D; Moore, M; Morris, C; Rubin, G; Smith, M; Stevenson, D, 2022)
"To compare esomeprazole alone with esomeprazole plus aspirin in the treatment of aspirin-related peptic ulcers and to investigate the independent factors associated with the failure of ulcer healing."9.16Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers. ( Chen, WC; Ger, LP; Hsu, PI; Lai, KH; Lin, SY; Liu, CP; Mar, GY, 2012)
"Famotidine is effective in the prevention of gastric and duodenal ulcers, and erosive oesophagitis in patients taking low-dose aspirin."9.14Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. ( Bezlyak, V; McCloskey, C; Prasad, R; Taha, AS, 2009)
"In patients with aspirin-related peptic ulcers/erosions, high-dose famotidine therapy is inferior to pantoprazole in preventing recurrent dyspeptic or bleeding ulcers/erosions."9.14Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. ( Chan, P; Chu, WM; Kng, C; Kwan, A; Lam, KF; Lau, YK; Ling, YH; Ng, FH; Wong, BC; Wong, SY; Yuen, WC, 2010)
"Whether or not the use of metformin decreases the risk of gastric adenocarcinoma is unclear."7.91Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study. ( Lagergren, J; Santoni, G; Xie, SH; Zheng, J, 2019)
"To evaluate the efficacy and safety of aspirin usage for coronary heart disease (CHD) primary prevention in patients with dyslipidemia."7.83Effects of low-dose aspirin in subjects with dyslipidemia. ( Chen, J; Lou, G; Xia, Y, 2016)
"This survey depicts individual discrepancies in the clinical management of patients receiving NSAIDs and/or aspirin, regarding the prophylaxis of gastroduodenal ulcer disease."7.78[Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori]. ( Armbruster, S; Mann, J; Schepp, W; Schneider, AR; Schuster, T; von Römer, W, 2012)
"The endoscopic characteristics of gastric ulcers in patients who were using non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin (LDA) and were infected with Helicobacter pylori remain unclear."7.78Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin. ( Abe, T; Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T; Yokoyama, S, 2012)
"Non-steroidal anti-inflammatory drug and aspirin (here collectively called NSAIDs) use is the second most common aetiologic factor for peptic ulcer disease and a major factor for peptic ulcer complications."7.71Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. ( Färkkilä, M; Juhola, M; Mäntynen, T; Sipponen, P; Voutilainen, M, 2001)
"To analyse the incidence and factors influencing the occurrence of UGIB in patients taking low-dose aspirin for the prevention of cardiovascular diseases outside clinical trials."7.71Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. ( Arroyo, MT; Ferreira, IJ; Lanas, A; Serrano, P, 2002)
"Endoscopic oesophageal and gastro-duodenal lesions were graded in 287 patients with reflux oesophagitis, median age 57 years, including 168 with oesophageal erosions, 131 infected with, 45 patients taking aspirin 75 mg daily, and 65 patients taking simple analgesics containing paracetamol/codeine."7.71Correlation between erosive oesophageal and gastro-duodenal diseases. the influence of aspirin, simple analgesics, and Helicobacter pylori. ( Angerson, WJ; Morran, CG; Taha, AS, 2002)
" Our aim was to investigate whether a similar blockade of inhibitory responses could be provoked by inducing gastritis with aspirin, thus implicating a common inflammatory component, possibly a proinflammatory cytokine(s)."7.70Aspirin-induced gastritis, like Helicobacter pylori-induced gastritis disinhibits acid secretion in humans: relation to cytokine expression. ( Hamlet, A; Lindholm, C; Nilsson, O; Olbe, L, 1998)
"Dyspepsia in the community is linked to smoking and aspirin use, but not to H pylori infection."7.70Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection. ( Hazel, S; Jones, M; Mitchell, H; Nandurkar, S; Talley, NJ; Xia, H, 1998)
"Current studies lack appropriate data on aspirin and other risk factors for gastrointestinal perforation."7.69Evidence of aspirin use in both upper and lower gastrointestinal perforation. ( Bajador, E; Benito, R; Esteva, F; Lanas, A; Sáinz, R; Serrano, P, 1997)
"Peptic ulcers in patients receiving aspirin are associated with Helicobacter pylori infection."5.51Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. ( Avery, A; Coupland, CAC; Crooks, C; Dumbleton, J; Hawkey, C; Hobbs, FDR; Kendrick, D; Moore, M; Morris, C; Rubin, G; Smith, M; Stevenson, D, 2022)
" pylori infection, use or abuse (often surreptitious) of high dose non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin (ASA) are the two major causes of true refractory ulcers."5.41Advances in the pharmacotherapeutic management of refractory peptic ulcers. ( Borao Laguna, C; Lanas, A, 2023)
"Aspirin has anti-inflammatory and antineoplastic activity."5.35Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils. ( Chan, AO; Chen, MH; Cho, CH; Gu, Q; Hu, PJ; Li, GQ; Liang, YJ; Lin, HL; Qiao, L; So, WH; Tatematsu, M; Tsukamoto, T; Wong, BC; Xia, HH; Yuen, MF, 2008)
" Patients with Helicobacter pylori infection and a history of peptic ulcer were assigned dual antiplatelet combination with omeprazole."5.17Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting. ( Chen, G; Du, Y; Hang, L; Ma, B, 2013)
"To compare esomeprazole alone with esomeprazole plus aspirin in the treatment of aspirin-related peptic ulcers and to investigate the independent factors associated with the failure of ulcer healing."5.16Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers. ( Chen, WC; Ger, LP; Hsu, PI; Lai, KH; Lin, SY; Liu, CP; Mar, GY, 2012)
"Famotidine is effective in the prevention of gastric and duodenal ulcers, and erosive oesophagitis in patients taking low-dose aspirin."5.14Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. ( Bezlyak, V; McCloskey, C; Prasad, R; Taha, AS, 2009)
"In patients with aspirin-related peptic ulcers/erosions, high-dose famotidine therapy is inferior to pantoprazole in preventing recurrent dyspeptic or bleeding ulcers/erosions."5.14Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. ( Chan, P; Chu, WM; Kng, C; Kwan, A; Lam, KF; Lau, YK; Ling, YH; Ng, FH; Wong, BC; Wong, SY; Yuen, WC, 2010)
"Owing to wide-spread use, low-dose aspirin (LDA) produces a substantial amount of peptic ulcer disease."5.01Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis. ( Grigg, SE; Sarri, GL; Yeomans, ND, 2019)
"Aspirin, even at low doses, has been known to cause upper gastro-intestinal complications, such as gastroduodenal ulcers, despite the definite benefits from its antithrombotic effects."4.91Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury. ( Iijima, K; Shimosegawa, T, 2015)
" pylori) infection, nonsteroidal anti-inflammatory drugs (NSAID) or low dose aspirin (ASA) use significantly and independently increased the risk for the development of peptic ulcer disease."4.90Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights. ( Gargallo, CJ; Lanas, A; Sostres, C, 2014)
" pylori infection and low-dose aspirin (LDA) are not only independent causal factors of peptic ulcer and gastrointestinal bleeding, they also have synergistic and additive effects."4.86[Influence of H. pylori infection on upper gastrointestinal damage]. ( Fukuzawa, M; Kawai, T; Moriyasu, F; Yamashina, A, 2010)
"Based on current references four clinical scenarios were discussed and different management strategies were compared for secondary and primary prophylaxis of ulcer or peptic ulcer bleeding under continuous therapy with non-steroidal antiinflammatory drugs (NSAID) or low-dose-aspirin, for H."4.82[Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. ( Ittel, TH; Limmer, S; Wietholtz, H, 2003)
"There were no significant differences in age, sex, alcohol consumption, smoking habits, history of diabetes, hypertension, and dyslipidemia, and aspirin intake between the eradication and non-eradication groups (3783 vs."4.31Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months. ( Ahn, S; Choi, Y; Hwang, IC; Kim, N; Kim, SB; Lee, DH; Lim, SH; Park, J; Park, YS; Shin, CM; Song, DH; Yoon, H, 2023)
"Whether or not the use of metformin decreases the risk of gastric adenocarcinoma is unclear."3.91Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study. ( Lagergren, J; Santoni, G; Xie, SH; Zheng, J, 2019)
" We evaluated the effects of aspirin on genetic/epigenetic alterations in precancerous conditions, i."3.85Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer. ( Das, KM; Fukui, H; Hara, K; Ito, C; Kondo, T; Kono, T; Michigami, Y; Miwa, H; Morimoto, T; Oshima, T; Tomita, T; Tozawa, K; Watari, J; Yamasaki, T, 2017)
"To evaluate the efficacy and safety of aspirin usage for coronary heart disease (CHD) primary prevention in patients with dyslipidemia."3.83Effects of low-dose aspirin in subjects with dyslipidemia. ( Chen, J; Lou, G; Xia, Y, 2016)
"Gastroduodenal ulcer and erosion are common in Japanese patients taking low dose aspirin for cardioprotection."3.80Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. ( Goto, S; Hiraishi, H; Ikeda, Y; Okada, Y; Origasa, H; Shimada, K; Sugano, K; Uchiyama, S; Uemura, N, 2014)
" In the management of aspirin-related uncomplicated peptic ulcers in patients requiring antiplatelet therapies, continuing aspirin plus a powerful proton pump inhibitor is the choice of treatment."3.78New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment. ( Hsu, PI, 2012)
"The endoscopic characteristics of gastric ulcers in patients who were using non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin (LDA) and were infected with Helicobacter pylori remain unclear."3.78Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin. ( Abe, T; Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T; Yokoyama, S, 2012)
"Recent data from Western countries indicate that the aetiology of peptic ulcer disease (PUD) is changing as the prevalence of Helicobacter pylori is decreasing while the use of low-dose aspirin (LDA, ≤325 mg/day) is increasing."3.78The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. ( Hopkins, M; Jorgensen, A; Moorcroft, J; Musumba, C; Pirmohamed, M; Pritchard, DM; Sutton, L; Van Eker, D, 2012)
"The frequencies of hemorrhagic spots, erosions and peptic ulcers in the symptomatic clopidogrel users were 25%, 39% and 39%, respectively."3.78Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy. ( Chan, HH; Chang, SN; Hsiao, SH; Hsu, PI; Huang, HR; Lai, KH; Lin, CH; Lin, CK; Lin, KH; Liu, CP; Tsai, TJ; Tsay, FW; Wang, HM; Wang, KM; Yu, HC, 2012)
"This survey depicts individual discrepancies in the clinical management of patients receiving NSAIDs and/or aspirin, regarding the prophylaxis of gastroduodenal ulcer disease."3.78[Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori]. ( Armbruster, S; Mann, J; Schepp, W; Schneider, AR; Schuster, T; von Römer, W, 2012)
"Low-dose aspirin (ASA) has emerged as one of the most important causes of peptic ulcer bleeding in developed countries."3.78Anti-platelet therapy and managing ulcer risk. ( Chan, FK, 2012)
"A total of 40 patients with functional dyspepsia (20 with Helicobacter pylori-negative chronic gastritis, and 20 with Helicobacter pylori-positive chronic gastritis), and 37 Helicobacter pylori-negative long-term non-steroidal anti-inflammatory drug users (26 with aspirin, 11 with selective cyclooxygenase-2 inhibitors) were selected."3.78Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa. ( Chen, J; Chen, LZ; Chen, MH; Mao, W; Peng, TL; Yin, XF, 2012)
"PPI was superior to H2-receptor antagonist for prevention of peptic ulcer, and cotreatment with AT1 receptor blocker or ACE inhibitor seemed to reduce peptic ulcer among patients taking low-dose aspirin."3.75Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. ( Haruma, K; Hata, J; Imamura, H; Kamada, T; Kusunoki, H; Manabe, N; Sakakibara, T; Shiotani, A; Tarumi, K; Yamanaka, Y, 2009)
" The records of H pylori status (CLO-test), endoscopic findings of GU, DU and gastritis, personal habits (smoking, alcohol intake) and medication [non-steroidal anti-inflammatory drugs (NSAIDs), aspirin intake] were analyzed using multi-way frequency analysis."3.74H pylori infection and other risk factors associated with peptic ulcers in Turkish patients: a retrospective study. ( Abasiyanik, MF; Bayyurt, N; Salih, BA; Sander, E, 2007)
"To analyse the incidence and factors influencing the occurrence of UGIB in patients taking low-dose aspirin for the prevention of cardiovascular diseases outside clinical trials."3.71Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. ( Arroyo, MT; Ferreira, IJ; Lanas, A; Serrano, P, 2002)
"Endoscopic oesophageal and gastro-duodenal lesions were graded in 287 patients with reflux oesophagitis, median age 57 years, including 168 with oesophageal erosions, 131 infected with, 45 patients taking aspirin 75 mg daily, and 65 patients taking simple analgesics containing paracetamol/codeine."3.71Correlation between erosive oesophageal and gastro-duodenal diseases. the influence of aspirin, simple analgesics, and Helicobacter pylori. ( Angerson, WJ; Morran, CG; Taha, AS, 2002)
", omeprazole, misoprostol, and high-dose famotidine) in the prevention of NSAID-induced gastroduodenal ulcers will also be effective in this setting."3.71Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. ( Lanas, AI, 2001)
"Non-steroidal anti-inflammatory drug and aspirin (here collectively called NSAIDs) use is the second most common aetiologic factor for peptic ulcer disease and a major factor for peptic ulcer complications."3.71Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. ( Färkkilä, M; Juhola, M; Mäntynen, T; Sipponen, P; Voutilainen, M, 2001)
" Our aim was to investigate whether a similar blockade of inhibitory responses could be provoked by inducing gastritis with aspirin, thus implicating a common inflammatory component, possibly a proinflammatory cytokine(s)."3.70Aspirin-induced gastritis, like Helicobacter pylori-induced gastritis disinhibits acid secretion in humans: relation to cytokine expression. ( Hamlet, A; Lindholm, C; Nilsson, O; Olbe, L, 1998)
"Dyspepsia in the community is linked to smoking and aspirin use, but not to H pylori infection."3.70Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection. ( Hazel, S; Jones, M; Mitchell, H; Nandurkar, S; Talley, NJ; Xia, H, 1998)
"Clinical and endoscopic findings as well as Helicobacter pylori status, gastric secretion analysis, serum gastrin levels, nonsteroidal anti-inflammatory drug (NSAID) use, and objective testing of aspirin use by platelet cyclooxygenase activity were studied in 60 consecutive refractory patients with peptic ulcer and 54 matched nonrefractory controls."3.69Risk factors associated with refractory peptic ulcers. ( Esteva, F; Lanas, AI; Remacha, B; Sáinz, R, 1995)
"Current studies lack appropriate data on aspirin and other risk factors for gastrointestinal perforation."3.69Evidence of aspirin use in both upper and lower gastrointestinal perforation. ( Bajador, E; Benito, R; Esteva, F; Lanas, A; Sáinz, R; Serrano, P, 1997)
"Low-dose aspirin is widely used in patients operated on for coronary disease as secondary prevention of coronary artery occlusion."3.68Gastric changes in coronary-operated patients with low-dose aspirin. ( Kivilaakso, E; Leivonen, M; Sipponen, P, 1992)
"Hence, peptic ulcer is the ulcer of both the stomach and the duodenum."3.01A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer. ( Ahmed, SI; Gogoi, HK; Kashyap, A; Maut, C; Roy, AJ, 2023)
" pylori-positive and 10-negative subjects) with 100 mg aspirin plus 75 mg clopidogrel (AC) once-daily dosing and AC plus 20 mg famotidine twice-daily dosing (ACH)."2.79Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine. ( Furuta, T; Ichikawa, H; Iwaizumi, M; Miyajima, H; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M, 2014)
"pylori gastritis was present than when it was absent, despite similar degrees of gastric mucosal prostaglandin depletion."2.70Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial. ( Cryer, B; Feldman, M; Go, MF; Mallat, D, 2001)
"Aspirin was most commonly used (43%)."2.69Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer. ( Fock, KM; Khor, JL; Machin, D; Ng, TM; Sim, CS; Tan, AL; Teo, EK, 2000)
" Furthermore, there is growing evidence that long-term use of aspirin decreases the risk of colorectal cancer, even at low doses."2.47Gastrointestinal effects of aspirin. ( Lanas, A; Sostres, C, 2011)
"Helicobacter pylori (H pylori) infection and the use of non-steroidal anti-inflammatory drugs (NSAIDs) including aspirin at any dosage and formulation represent well-established risk factors for the development of uncomplicated and complicated peptic ulcer disease accounting for the majority of such cases."2.43Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. ( Archimandritis, AJ; Papatheodoridis, GV, 2005)
"Aspirin has a role in the prevention of cardiovascular and cerebrovascular disease, Alzheimer's dementia and several cancers."2.42Review article: the ageing bowel and intolerance to aspirin. ( Johns, CE; May, FE; Newton, JL, 2004)
" Dosing should be [figure: see text] cautious in old patients, however, because of the ability of NSAIDs and coxibs to cause fluid retention, heart failure, and hypertension."2.41Gastrointestinal safety of COX-2 specific inhibitors. ( Hawkey, CJ; Jones, JI, 2001)
"Over 80% of recurrences are infrequent and can be treated when they occur n 20% of ulcer patients have 3 recurrences/yr, ulcer complications, or such poor health that recurrence might prove fatal."2.38Maintenance therapy for peptic ulcer--who needs it? ( McCarthy, DM, 1993)
"Aspirin use was associated with a frequency-, dose-, and duration-dependent reduction in GC risk after HP eradication."1.48Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study. ( Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, AYS; Wong, ICK, 2018)
"Dyspepsia is a common problem in the community and clinical practice with symptom(s) considered arising from the gastroduodenal region."1.48Uninvestigated dyspepsia and associated factors of patients with gastrointestinal disorders in Dessie Referral Hospital, Northeast Ethiopia. ( Demsiss, W; Seid, A; Tamir, Z, 2018)
"Epidemiological studies on aspirin and stomach cancer have been inconclusive."1.42Regular aspirin use and stomach cancer risk in China. ( Duan, H; Ge, J; Shen, C; Wang, Y, 2015)
"Once gastrointestinal hemorrhage has occurred, several studies have indicated the need to implement simpler prognostic scales than those used today."1.38[Gastrointestinal bleeding associated with NSAIDs, antiplatelet therapy and anticoagulant agent]. ( Lanas, A, 2012)
"The incidence of esophageal and gastric cancers was high at 5."1.36Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study. ( Kawai, T; Watanabe, M; Yamashina, A, 2010)
"Aspirin has anti-inflammatory and antineoplastic activity."1.35Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils. ( Chan, AO; Chen, MH; Cho, CH; Gu, Q; Hu, PJ; Li, GQ; Liang, YJ; Lin, HL; Qiao, L; So, WH; Tatematsu, M; Tsukamoto, T; Wong, BC; Xia, HH; Yuen, MF, 2008)
"Diclofenac and aspirin were most common NSAIDs associated with peptic ulcers in 32."1.33Frequency of NSAID induced peptic ulcer disease. ( Abid, S; Hamid, S; Islam, M; Islam, S; Jafri, W; Yakoob, J, 2006)
"Uninvestigated dyspepsia is common in family practice."1.32The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. ( Armstrong, D; Barkun, AN; Chakraborty, B; Chiba, N; Daniels, S; Escobedo, S; Sinclair, P; Thomson, AB; Van Zanten, SJ; White, RJ, 2003)
"A case-control study of stomach cancer which includes 448 cases and 610 hospital controls has been conducted in Moscow, Russia."1.30Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. ( Borisova, E; Chkhikvadze, V; Maximovitch, D; Zaridze, D, 1999)

Research

Studies (257)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's21 (8.17)18.2507
2000's130 (50.58)29.6817
2010's85 (33.07)24.3611
2020's21 (8.17)2.80

Authors

AuthorsStudies
Gajewski, AŁ1
Gawrysiak, M1
Krupa, A1
Rechciński, T1
Chałubiński, M1
Gonciarz, W1
Chmiela, M1
Lanas, A22
Santilli, F1
Hawkey, C2
Avery, A1
Coupland, CAC1
Crooks, C1
Dumbleton, J1
Hobbs, FDR1
Kendrick, D1
Moore, M1
Morris, C1
Rubin, G1
Smith, M1
Stevenson, D1
Yadlapati, R2
Roy, AJ2
Maut, C2
Gogoi, HK2
Ahmed, SI2
Kashyap, A2
Liuzzo, G1
Patrono, C1
Kim, SB1
Kim, N3
Park, J1
Hwang, IC1
Lim, SH1
Song, DH1
Choi, Y1
Yoon, H1
Shin, CM1
Park, YS2
Lee, DH2
Ahn, S1
Perisetti, A1
Sharma, P1
Borao Laguna, C1
Gatta, L1
Zullo, A2
Vaira, D1
Watari, J3
Tomita, T3
Tozawa, K2
Oshima, T3
Fukui, H3
Miwa, H3
Zheng, J1
Xie, SH1
Santoni, G1
Lagergren, J1
Scheiman, JM4
Oura, H1
Matsumura, T1
Kawasaki, Y1
Okimoto, K1
Ishikawa, K1
Kaneko, T1
Tokunaga, M1
Oike, T1
Imai, Y2
Yokoyama, Y1
Akizue, N1
Maruoka, D1
Ohta, Y1
Saito, K1
Nakagawa, T1
Arai, M1
Kato, J1
Kato, N1
Ahn, JY1
Yang, HJ1
Vasapolli, R1
Venerito, M3
Schirrmeister, W1
Thon, C1
Weigt, J1
Wex, T5
Malfertheiner, P9
Link, A1
Guo, CG2
Zhang, F2
Wu, JT1
Cheung, KS3
Li, B1
Law, SYK1
Leung, WK4
Kamal, H1
Sadr-Azodi, O1
Engstrand, L2
Brusselaers, N1
Mojkowska, A1
Gazdzinski, S1
Fraczek, M1
Wyleżoł, M1
Kawasaki, K1
Nakamura, S1
Kurahara, K1
Nagasue, T1
Yanai, S1
Harada, A1
Yaita, H1
Fuchigami, T1
Matsumoto, T2
Negovan, A2
Iancu, M1
Moldovan, V1
Sàrkàny, K1
Bataga, S2
Mocan, S2
Țilea, I1
Banescu, C1
Shan, J1
Lei, H1
Shi, W1
Sun, X1
Tang, Y1
Ren, C1
Michigami, Y1
Ito, C1
Hara, K1
Yamasaki, T2
Kondo, T2
Kono, T1
Morimoto, T1
Das, KM1
Seid, A1
Tamir, Z1
Demsiss, W1
Chan, EW2
Wong, AYS1
Chen, L2
Seto, WK1
Wong, ICK1
Cuzick, J1
Dumonceau, JM1
Hunt, RH3
Fujishiro, M1
Gralnek, IM1
Campbell, HE1
Rostom, A1
Villanueva, C1
Sung, JJY1
Fukushi, K1
Tominaga, K1
Nagashima, K1
Kanamori, A1
Izawa, N1
Kanazawa, M1
Sasai, T2
Hiraishi, H3
Ng, JC1
Yeomans, ND3
Sostres, C5
Luo, PJ1
Lin, XH1
Lin, CC1
Luo, JC4
Hu, HY1
Ting, PH1
Hou, MC1
Sarri, GL1
Grigg, SE1
Pantea, M1
Voidăzan, S1
Macarie, M1
Wong, IC1
Iwamoto, J1
Saito, Y1
Honda, A1
Matsuzaki, Y1
Kawai, T4
Fukuzawa, M3
Moriyasu, F3
Yamashina, A4
Tan, VP1
Wong, BC4
Uemura, N3
Sugano, K1
Shimada, K1
Goto, S1
Uchiyama, S1
Okada, Y1
Origasa, H1
Ikeda, Y1
Labenz, J1
Mousavi, M1
Salehimarzijarani, B1
Dadvar, Z1
Jalalay, NY1
Valizadeh, N1
Sotoudeh, H1
Zali, M1
Kim, SG1
Jung, HK2
Lee, HL1
Jang, JY1
Lee, H1
Kim, CG1
Shin, WG1
Shin, ES1
Lee, YC2
Charpignon, C1
Lesgourgues, B1
Pariente, A1
Nahon, S1
Pelaquier, A1
Gatineau-Sailliant, G1
Roucayrol, AM1
Courillon-Mallet, A1
Ma, B1
Hang, L1
Chen, G1
Du, Y1
Higuchi, T1
Iwakiri, R2
Hara, M2
Shimoda, R2
Sakata, Y1
Nakayama, A1
Nio, K1
Yamaguchi, S1
Yamaguchi, D1
Watanabe, A1
Akutagawa, T1
Sakata, H2
Fujimoto, K2
Uotani, T1
Sugimoto, M1
Nishino, M1
Ichikawa, H3
Sahara, S1
Yamade, M1
Iwaizumi, M1
Yamada, T1
Osawa, S1
Sugimoto, K1
Umemura, K1
Watanabe, H2
Miyajima, H1
Furuta, T1
Iijima, K5
Koike, T3
Ara, N3
Nakagawa, K1
Kondo, Y1
Uno, K3
Hatta, W1
Asano, N3
Imatani, A2
Shimosegawa, T5
González-Pérez, A1
Sáez, ME1
Johansson, S1
Nagy, P1
García Rodríguez, LA1
Gargallo, CJ2
Lim, YJ1
Hong, SJ1
Nagata, N1
Niikura, R1
Sekine, K1
Sakurai, T1
Shimbo, T1
Kishida, Y1
Tanaka, S1
Aoki, T1
Okubo, H1
Watanabe, K2
Yokoi, C1
Akiyama, J1
Yanase, M1
Mizokami, M1
Rotondano, G1
Wang, Y1
Shen, C1
Ge, J1
Duan, H1
Carrera-Lasfuentes, P1
Benito, R3
Roncales, P1
Arruebo, M1
Arroyo, MT2
Bujanda, L1
García-Rodríguez, LA1
Chung, WC1
Jeon, EJ1
Kim, DB1
Sung, HJ1
Kim, YJ1
Lim, ES1
Kim, MA1
Oh, JH1
Wu, Y1
Hu, Y1
You, P1
Chi, YJ1
Zhou, JH1
Zhang, YY1
Liu, YL1
Wilson, N1
Selak, V1
Blakely, T1
Leung, W1
Clarke, P1
Jackson, R1
Knight, J1
Nghiem, N1
Shim, YK1
Lou, G1
Chen, J3
Xia, Y1
Begovic, G1
Selmani, R1
Yanaka, A1
Treiber, G6
Kuester, D3
Roessner, A4
Mönkemüller, K1
Vieth, M4
Krieg, A1
Bhatt, DL1
Scheiman, J2
Abraham, NS1
Antman, EM1
Chan, FK10
Furberg, CD1
Johnson, DA2
Mahaffey, KW1
Quigley, EM3
Harrington, RA1
Bates, ER1
Bridges, CR1
Eisenberg, MJ1
Ferrari, VA1
Hlatky, MA1
Kaul, S1
Lindner, JR1
Moliterno, DJ1
Mukherjee, D1
Schofield, RS1
Rosenson, RS1
Stein, JH1
Weitz, HH1
Wesley, DJ1
Vestergård, A1
Bredahl, K1
de Muckadell, OB1
Pedersen, OB1
Hansen, JM1
Nardulli, G1
Tahara, T1
Shibata, T1
Nakamura, M1
Yamashita, H1
Yoshioka, D1
Okubo, M1
Maruyama, N1
Kamano, T1
Kamiya, Y1
Fujita, H1
Nagasaka, M1
Iwata, M1
Takahama, K1
Watanabe, M3
Hirata, I1
Arisawa, T1
Shiotani, A2
Sakakibara, T2
Yamanaka, Y2
Imamura, H2
Tarumi, K2
Manabe, N1
Kamada, T2
Kusunoki, H1
Hata, J2
Haruma, K2
Sung, JJ5
Kuipers, EJ2
El-Serag, HB1
Lanza, FL2
Dai, X1
Makaryus, AN1
Makaryus, JN1
Jauhar, R1
Hermansson, M1
Ekedahl, A1
Ranstam, J1
Zilling, T1
Nakayama, M1
Ootani, H1
Tsunada, S1
Chiu, PW1
Ng, EK1
Leong, RW1
Hawkey, CJ8
Taha, AS2
McCloskey, C1
Prasad, R1
Bezlyak, V1
Gil, J1
Wojtuń, S1
Nayeb-Hashemi, H1
Kaunitz, JD1
Yang, P1
Zhou, Y1
Chen, B1
Wan, HW1
Jia, GQ1
Bai, HL1
Wu, XT1
McColl, KE1
Chang, FY2
Chen, TS2
Ng, YY1
Lin, HC1
Lu, CL1
Chen, CY1
Lin, HY1
Lee, SD1
Hart, J1
Naesdal, J1
Talley, NJ4
Thomson, AB2
Ng, FH1
Wong, SY1
Lam, KF1
Chu, WM1
Chan, P1
Ling, YH1
Kng, C1
Yuen, WC1
Lau, YK1
Kwan, A1
Lee, JH2
Jeon, SW1
Kim, JW2
Lee, SW1
Gargallo, C1
Görgens, D1
Langner, C1
Sbrozzi-Vanni, A1
Di Giulio, E1
Hassan, C1
Corleto, VD1
Lahner, E1
Annibale, B1
Cho, DK1
Park, SY1
Kee, WJ1
Ki, HS1
Yoon, KW1
Cho, SB1
Lee, WS1
Joo, YE1
Kim, HS1
Choi, SK1
Rew, JS1
Pilotto, A3
Franceschi, M3
Maggi, S1
Addante, F1
Sancarlo, D1
Nomura, M1
Nishi, R1
Fletcher, EH1
Johnston, DE1
Fisher, CR1
Koerner, RJ1
Newton, JL2
Gray, CS1
Kim, JJ1
Lee, BH1
Kang, JM1
Seo, P1
Lim, MK1
Kwon, JH1
Song, BJ1
Lee, JW1
Lee, SH1
Hwang, JH1
Jeong, SH1
Jung, HC1
Song, IS1
Kato, M1
Ono, S1
Yoshida, T1
Mabe, K1
Shimizu, Y1
Asaka, M1
Abe, Y2
Iwai, W1
Ohara, S1
Bae, SE1
Kim, SE1
Jung, SA1
Yoon, SY1
Shim, KN1
Kim, TH1
Yoo, K1
Moon, IH1
Furukawa, M1
Fujita, M1
Takinishi, A1
Misaka, R1
Nagahara, H1
Gokturk, HS1
Demir, M1
Unler, GK1
Erbayrak, M1
Sakalli, M1
Yilmaz, U1
Bor, S1
Dağli, U1
Sarer, B1
Gürel, S1
Tözün, N2
Sıvrı, B1
Akbaş, T1
Sahın, B1
Memık, F1
Batur, Y1
Hsu, PI3
Kim, Y1
Yokoyama, S1
Hori, K1
Okugawa, T1
Toyoshima, F1
Sakurai, J1
Tanaka, J1
Abe, T1
Tomiyama, H1
Liu, CP2
Chen, WC1
Lai, KH2
Mar, GY1
Lin, SY1
Ger, LP1
Valkhoff, VE1
Sturkenboom, MC1
Leung Ki, EL1
Iwabuchi, T1
Shinkai, H1
Endo, H1
Musumba, C1
Jorgensen, A1
Sutton, L1
Van Eker, D1
Moorcroft, J1
Hopkins, M1
Pritchard, DM1
Pirmohamed, M1
Goh, KL2
Chan, WK1
Mao, W1
Peng, TL1
Yin, XF1
Chen, LZ1
Chen, MH2
Calvet, X1
Gisbert, JP1
Schneider, AR1
Armbruster, S1
Mann, J1
von Römer, W1
Schuster, T1
Schepp, W1
Tsai, TJ1
Lin, CK1
Chan, HH1
Yu, HC1
Wang, HM1
Lin, KH1
Wang, KM1
Chang, SN1
Hsiao, SH1
Huang, HR1
Lin, CH1
Tsay, FW1
Ching, JY1
Suen, BY2
Tse, YK1
Wu, JC2
Müller, H1
Stolte, M1
Serrano, P3
Ferreira, IJ1
Maiden, LP1
Harris, AW1
Angerson, WJ1
Morran, CG1
Guda, N1
Vakil, N1
Wepner, U1
Shah, AA1
Byrne, MF1
Cullen, L1
Walsh, T1
Fitzgerald, DJ1
Murray, FE2
Monés Xiol, J1
Lehmann, FS1
Gyr, N1
Thiéfin, G3
Wardi, J1
Shirin, H1
McKeogh, DF1
Barkun, AN1
Armstrong, D1
Chiba, N1
White, RJ1
Daniels, S1
Escobedo, S1
Chakraborty, B1
Sinclair, P1
Van Zanten, SJ1
Limmer, S1
Ittel, TH1
Wietholtz, H1
Kaffes, A1
Cullen, J1
Mitchell, H2
Katelaris, PH1
Hirschowitz, BI2
Füessl, HS2
Johns, CE1
May, FE1
Schwabe, M1
Ammon, S1
Walker, S1
Klotz, U1
Bazzoli, F2
Chaussade, S1
Abitbol, V1
Graham, DY3
Singh, G1
Giral, A1
Ozdogan, O1
Celikel, CA1
Ulusoy, NB1
Kalayci, C1
Leandro, G2
Longo, MG1
Perri, F1
Scarcelli, C2
Jolly, D1
Czernichow, P1
Merle, V1
Koop, H1
van Oijen, MG1
Laheij, RJ2
Peters, WH1
Jansen, JB2
Verheugt, FW2
Longoa, MG1
Orsitto, G1
Perri, FC1
D'Ambrosio, LP1
Konturek, PC4
Kania, J2
Gessner, U1
Konturek, SJ6
Hahn, EG3
Konturek, JW7
Arkkila, PE1
Seppälä, K1
Kosunen, TU1
Sipponen, P3
Mäkinen, J1
Rautelin, H1
Färkkilä, M2
Bobrzyński, A1
Płonka, M1
Bielański, W1
Karcz, D1
Park, SH1
Park, DI1
Kim, SH1
Kim, HJ1
Cho, YK1
Sung, IK1
Sohn, CI1
Jeon, WK1
Kim, BI1
Keum, DK1
Nakashima, S1
Arai, S1
Mizuno, Y1
Yoshino, K1
Ando, S1
Nakamura, Y3
Sugawara, K1
Koike, M1
Saito, E1
Naito, M1
Nakao, M1
Ito, H2
Hamaoka, K1
Rai, F1
Asakura, Y1
Akamatu, M1
Fujimori, K1
Inao, M1
Ota, S2
Fujiwara, K1
Shiibashi, M1
Papatheodoridis, GV1
Archimandritis, AJ1
Ebert, MP1
Schäfer, C1
Hoffmann, J1
Gu, P1
Kubisch, C1
Carl-McGrath, S1
Röcken, C1
Rossini, R1
Lucà, MG1
Scuri, P1
Invernizzi, P1
Strazzabosco, M1
Gavazzi, A1
Nakajima, S1
Bamba, H1
Ye, S1
Yuan, Y1
Padol, IT1
Chey, WD1
Eswaren, S1
Howden, CW1
Inadomi, JM1
Fendrick, AM1
Agustí-Escasany, A1
Vallano-Ferraz, A1
Fass, R1
Modlin, IM1
Malagelada, JR1
Moss, SF1
Holtmann, G2
Katelaris, P1
Stanghellini, V1
Tytgat, GN1
Wright, NA1
Di Mario, F1
Hamid, S1
Yakoob, J1
Jafri, W1
Islam, S1
Abid, S1
Islam, M1
Ji, KY1
Hu, FL1
Ferrandez, A1
Stiefelhagen, P1
Becker, JC1
Domschke, W6
Pohle, T1
Yilmaz, S1
Bayan, K1
Dursun, M1
Canoruç, F1
Kilinç, N1
Tüzün, Y1
Daniş, R1
Ertem, M1
Ferrara, M1
Coppola, L1
Coppola, A1
Capozzi, L1
Salih, BA1
Abasiyanik, MF1
Bayyurt, N1
Sander, E1
Fabijanic, D1
Banic, M1
Kardum, D1
Sutlic, Z1
Radic, M1
Rudez, I1
Biocina, B1
Roth, BE1
Cherian, PT1
Cherian, S1
Singh, P1
Li, GQ1
Xia, HH1
Tsukamoto, T1
Tatematsu, M1
Gu, Q1
Qiao, L1
Cho, CH1
So, WH1
Yuen, MF2
Hu, PJ1
Liang, YJ1
Lin, HL1
Chan, AO2
Piazuelo, E1
Fuentes, J2
García-González, MA1
Jiménez, P1
Tseng, GY1
Lin, HJ1
Lanas, AI3
Remacha, B1
Esteva, F2
Sáinz, R3
McCarthy, DM1
Goebell, H1
Holtmann, M1
Schubert, TT2
Bologna, SD2
Nensey, Y1
Schubert, AB1
Mascha, EJ1
Ma, CK2
Rabassa, AA1
Goodgame, R1
Sutton, FM1
Ou, CN1
Rognerud, C1
Bajador, E2
Prach, AT1
Senior, BW1
Hopwood, D1
McBride, PD1
MacDonald, TM1
Kerr, MA1
Gambassi, G1
Festa, V1
Bernabei, R1
Dembiński, A2
Cullen, DJ1
Hawkey, GM2
Greenwood, DC1
Humphreys, H1
Shepherd, V1
Logan, RF2
Kordecki, H1
Kurowski, M1
Kosik, R1
Pilecka, D1
Stachura, J2
Hamlet, A1
Lindholm, C1
Nilsson, O1
Olbe, L1
Nandurkar, S1
Xia, H1
Hazel, S1
Jones, M1
Beales, IL1
Zaridze, D1
Borisova, E1
Maximovitch, D1
Chkhikvadze, V1
Ishikawa, H1
Higaki, M2
Matsumoto, Y1
Kamimura, T1
Katsura, Y1
Tomishi, T1
Inoue, Y1
Takasugi, H1
Tomoi, M1
Krakowka, S1
Yoshida, K1
Ng, TM1
Fock, KM1
Khor, JL1
Teo, EK1
Sim, CS1
Tan, AL1
Machin, D1
Atherton, JC2
Wight, NJ1
Hochain, P1
Capet, C1
Colin, R1
Mitobe, Y1
Shimada, T1
Terano, A1
Feldman, M2
Shewmake, K1
Cryer, B3
Akre, K2
Signorello, LB2
Bergström, R1
Larsson, S1
Eriksson, BI1
Nyrén, O2
Russell, RI1
Chung, SC1
Lee, YT1
Leung, VK1
Lau, JY1
Hui, Y1
Lai, MS1
Chan, HL1
Ekström, AM1
Hansson, LE1
Fischer, H2
Huber, V2
Boknik, P2
Luess, H2
Neumann, J2
Brzozowski, T1
Schmitz, W2
Mallat, D1
Go, MF1
Verbeek, AL1
Jacobson, BC1
Voutilainen, M1
Mäntynen, T1
Juhola, M1
Aalykke, C1
Lauritsen, K1
Slomiany, BL1
Piotrowski, J1
Slomiany, A1
Jones, JI1
Peek, RM1
Stack, WA1
Schmassmann, A1
Yoshida, N2
Sugimoto, N2
Hirayama, F1
Naito, Y2
Yoshikawa, T2
Ochiai, J1
Hoshiya, S1
Tokunaga, K1
Tanaka, A1
Nagamatsu, S1
Ishida, H1
Takahashi, S1
Zambrana, JL1
Rodríguez-González, FJ1
Puente, J1
Wildgrube, HJ1
Kierschke, G1
Nowak, H1
Weigmann, I1
Terhaag, B1
Lai, KC1
Lam, SK1
Chu, KM1
Hui, WM1
Hu, WH1
Lau, GK1
Wong, WM1
Lai, CL1
Wong, J1
Leivonen, M1
Kivilaakso, E1
Nensey, YM1
Evans, DG1

Clinical Trials (14)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Endoscopic Diagnosis, Treatment and Prognosis of Acute Nonvariceal Upper Gastrointestinal Bleeding in Nanchang, Jiangxi Province, China.[NCT04895904]3,200 participants (Actual)Observational2014-09-01Completed
Factors Predicting the Need for Endoscopic Intervention in Non-variceal Upper Gastrointestinal Bleeding[NCT05979025]262 participants (Actual)Observational2022-08-11Completed
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction Trial Based on the SWEDEHEART Registry (HELP-SWEDEHEART)[NCT05024864]22,000 participants (Anticipated)Interventional2021-11-17Recruiting
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction Pilot Study[NCT04289012]300 participants (Actual)Interventional2019-11-07Completed
Risk of Uncomplicated Peptic Ulcer in the General Population[NCT01888588]4,000 participants (Actual)Observational2012-09-30Completed
Falciformopexy for Treatment Perforated Peptic[NCT05715450]25 participants (Anticipated)Interventional2023-05-30Not yet recruiting
Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases: A Multicenter, Randomized, Double-blinded, Controlled Trial[NCT03320538]360 participants (Anticipated)Interventional2017-07-10Recruiting
Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer[NCT02418312]228 participants (Actual)Interventional2012-01-31Completed
Comparison of Two Rescue Therapies for Helicobacter Pylori Infection - A Multicenter Randomized Controlled Trial[NCT02547012]51 participants (Actual)Interventional2013-11-30Completed
Data-driven Quality Improvement in Primary Care: Cluster Randomised Controlled Trial to Test the Effectiveness of a Multifaceted Intervention in Reducing High Risk Prescribing of Non-steroidal Anti-inflammatory Drugs and Antiplatelet Agents[NCT01425502]33 participants (Actual)Interventional2012-09-30Completed
Pantoprazole Versus Famotidine for the Prevention of Recurrent Peptic Ulcers in Thienopyridine Users - a Double-blind Randomized Controlled Trial[NCT02551744]101 participants (Actual)Interventional2012-07-31Completed
Eradication of Helicobacter Pylori According to 23S rRNA Point Mutations Associated With Clarithromycin Resistance[NCT01453036]Phase 4924 participants (Actual)Interventional2011-08-31Completed
WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)[NCT02741817]Phase 420 participants (Actual)Interventional2016-06-26Completed
European Registry on the Management of Helicobacter Pylori Infection[NCT02328131]10,000 participants (Anticipated)Observational2013-06-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants With Healed Peptic Ulcer

Follow-up endoscopy was performed at the end of the 6th month (NCT02418312)
Timeframe: 6 months

Interventionparticipants (Number)
Histamine-2 Receptor Antagonist Group106
Placebo Group101

Number of Participants in Which H. Pylori Was Eradicated

Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02547012)
Timeframe: six weeks after the end of anti-H pylori therapy.

Interventionparticipants (Number)
Esomeprazole+Amox+Levo+Tetra13
Esomeprazole+Amox+Levo21

Number of Participants With Ulcer Recurrence

Follow-up endoscopy was performed at the end of the 6th month (NCT02551744)
Timeframe: six month

Interventionparticipants (Number)
Proton Pump Inhibitor Group1
Histamine-2 Receptor Antagonist Group7

Helicobacter Pylori Eradication Rate

Eradication was determined by the C13-urea breath test 6 to 8 weeks after the eradication therapy when PPIs had not been used for at least 2 weeks. (NCT01453036)
Timeframe: 8 weeks

Interventionpercentage of participants (Number)
Convential AOC Group75.9
Mutation Test Group91.2
Convential AOM Group79.1

Reviews

74 reviews available for aspirin and Infections, Helicobacter

ArticleYear
A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer.
    Current drug discovery technologies, 2023, Volume: 20, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Humans; Inflammation; Pep

2023
A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer.
    Current drug discovery technologies, 2023, Volume: 20, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Humans; Inflammation; Pep

2023
A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer.
    Current drug discovery technologies, 2023, Volume: 20, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Humans; Inflammation; Pep

2023
A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer.
    Current drug discovery technologies, 2023, Volume: 20, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Humans; Inflammation; Pep

2023
Advances in the pharmacotherapeutic management of refractory peptic ulcers.
    Expert opinion on pharmacotherapy, 2023, Volume: 24, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma

2023
Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of
    Gut and liver, 2020, 05-15, Volume: 14, Issue:3

    Topics: Aspirin; Endoscopic Mucosal Resection; Female; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Inf

2020
Prevention of Peptic Ulcer Associated with Aspirin and Antiplatelet Agent.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2020, 11-25, Volume: 76, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicobacter Infections; Helico

2020
Management of Peptic Ulcer Bleeding in Patients Taking Aspirin or Anticoagulant.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2020, 11-25, Volume: 76, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenal Ulcer; Helicobacter Infec

2020
Non-variceal upper gastrointestinal bleeding.
    Nature reviews. Disease primers, 2018, 04-19, Volume: 4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenum; Endoscopy; Esophagus; Ga

2018
Non-variceal upper gastrointestinal bleeding.
    Nature reviews. Disease primers, 2018, 04-19, Volume: 4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenum; Endoscopy; Esophagus; Ga

2018
Non-variceal upper gastrointestinal bleeding.
    Nature reviews. Disease primers, 2018, 04-19, Volume: 4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenum; Endoscopy; Esophagus; Ga

2018
Non-variceal upper gastrointestinal bleeding.
    Nature reviews. Disease primers, 2018, 04-19, Volume: 4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenum; Endoscopy; Esophagus; Ga

2018
Helicobacter pylori infection and the risk of upper gastrointestinal bleeding in low dose aspirin users: systematic review and meta-analysis.
    The Medical journal of Australia, 2018, Sep-01, Volume: 209, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Aspirin; Helicobacter Infections; Helicobacter pylori; Humans; Middl

2018
Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:3

    Topics: Aspirin; Databases, Bibliographic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans;

2019
Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:3

    Topics: Aspirin; Databases, Bibliographic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans;

2019
Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:3

    Topics: Aspirin; Databases, Bibliographic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans;

2019
Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:3

    Topics: Aspirin; Databases, Bibliographic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans;

2019
Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
    World journal of gastroenterology, 2013, Mar-21, Volume: 19, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1;

2013
[Antithrombotic drug and gastrointestinal injuries].
    Nihon rinsho. Japanese journal of clinical medicine, 2013, Volume: 71, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Fibrinolytic Agents; Gastrointestinal Hemorrhage;

2013
Gastric cancer chemoprevention: the current evidence.
    Gastroenterology clinics of North America, 2013, Volume: 42, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2 Inhibitors

2013
Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights.
    World journal of gastroenterology, 2014, Jul-28, Volume: 20, Issue:28

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Helicobacter Inf

2014
Helicobacter pylori infection in nonsteroidal anti-inflammatory drug users.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Volume: 64, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma

2014
Epidemiology and diagnosis of acute nonvariceal upper gastrointestinal bleeding.
    Gastroenterology clinics of North America, 2014, Volume: 43, Issue:4

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Duodenal Diseases; Endoscopy, Gastr

2014
Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.
    Journal of gastroenterology, 2015, Volume: 50, Issue:6

    Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combi

2015
Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
    World journal of gastroenterology, 2015, Jul-07, Volume: 21, Issue:25

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Asia; Aspirin; Australia; Duodenal Ulcer; Duodenum; Europe;

2015
Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
    Current pharmaceutical design, 2015, Volume: 21, Issue:35

    Topics: Animals; Aspirin; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Helicobacter Infectio

2015
[Nonsteroidal Anti-inflammatory Drug and Aspirin-induced Peptic Ulcer Disease].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2016, Jun-25, Volume: 67, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Membrane Permeability;

2016
Role of Sulforaphane in Protection of Gastrointestinal Tract Against H. pylori and NSAID-Induced Oxidative Stress.
    Current pharmaceutical design, 2017, Volume: 23, Issue:27

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastric Mucosa; Gastritis; Gastrointestin

2017
[Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
    Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal

2009
Systematic review: the global incidence and prevalence of peptic ulcer disease.
    Alimentary pharmacology & therapeutics, 2009, May-01, Volume: 29, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Female; Helicobacter Infections

2009
Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Reviews in cardiovascular medicine, 2009,Winter, Volume: 10, Issue:1

    Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Aspirin; Clopidogrel; Coro

2009
Predicting poor outcome from acute upper gastrointestinal hemorrhage.
    Gastroenterology clinics of North America, 2009, Volume: 38, Issue:2

    Topics: Aging; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Endoscopy, Gastrointestinal; Esophageal and

2009
Differences in peptic ulcer between the East and the West.
    Gastroenterology clinics of North America, 2009, Volume: 38, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Drug Resistance, Bacterial; Glo

2009
Gastroduodenal mucosal defense.
    Current opinion in gastroenterology, 2009, Volume: 25, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bicarbonates; Duodenum; Gastric Mucosa; Helicobact

2009
Aspirin use and the risk of gastric cancer: a meta-analysis.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Chi-Square Distribution;

2010
Peptic ulcer disease.
    Lancet (London, England), 2009, Oct-24, Volume: 374, Issue:9699

    Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biopsy; Gastroscopy;

2009
Drug-related damage of the ageing gastrointestinal tract.
    Best practice & research. Clinical gastroenterology, 2009, Volume: 23, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-St

2009
Optimal management of peptic ulcer disease in the elderly.
    Drugs & aging, 2010, Jul-01, Volume: 27, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; He

2010
Aspirin-induced peptic ulcer and genetic polymorphisms.
    Journal of gastroenterology and hepatology, 2010, Volume: 25 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Aspirin; Cyclooxygenase 1; C

2010
Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
    Expert opinion on drug safety, 2011, Volume: 10, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Gastrointestinal

2011
Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin.
    Alimentary pharmacology & therapeutics, 2010, Volume: 32, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infectio

2010
[Pathologic characteristics of gastric ulcer in the aged].
    Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:11

    Topics: Aged; Aspirin; Helicobacter Infections; Helicobacter pylori; Humans; Stomach Ulcer

2010
[Influence of H. pylori infection on upper gastrointestinal damage].
    Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:11

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylor

2010
Gastrointestinal effects of aspirin.
    Nature reviews. Gastroenterology & hepatology, 2011, Jun-07, Volume: 8, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Gastric Mucosa; Gastroint

2011
Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
    Best practice & research. Clinical gastroenterology, 2012, Volume: 26, Issue:2

    Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cardiovascular Diseas

2012
Helicobacter pylori-negative peptic ulcer. What is its aetiopathogenesis and treatment?
    Revista espanola de enfermedades digestivas, 2002, Volume: 94, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; False Negative Reactions; Helicobacter Infections;

2002
[The future of peptic ulcer disease without Helicobacter].
    Praxis, 2003, Mar-19, Volume: 92, Issue:12

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin

2003
[Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].
    Gastroenterologie clinique et biologique, 2003, Volume: 27, Issue:3 Pt 2

    Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationsh

2003
Non-steroidal anti-inflammatory drug-induced gastroduodenal toxicity and Helicobacter pylori.
    The Israel Medical Association journal : IMAJ, 2003, Volume: 5, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Cell Division; Clinical Trials as Topic

2003
[Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
    Gastroenterologie clinique et biologique, 2003, Volume: 27, Issue:5

    Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Aspirin; Cyclooxygenase Inhi

2003
[Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:8

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Gastrointestinal

2003
Usual and unusual causes of duodenal ulcer.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Duodenal Ulcer; Helicobacter Infections; Helicobac

2003
Review article: the ageing bowel and intolerance to aspirin.
    Alimentary pharmacology & therapeutics, 2004, Jan-01, Volume: 19, Issue:1

    Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Forecasting; Gastrointestinal Disease

2004
Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
    Alimentary pharmacology & therapeutics, 2004, Volume: 19 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma

2004
[Role of Helicobacter pylori in drug-induced gastrointestinal bleeding].
    Presse medicale (Paris, France : 1983), 2003, Nov-22, Volume: 32, Issue:37 Pt 2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relations

2003
Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Alimentary pharmacology & therapeutics, 2004, May-15, Volume: 19, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase 2; Decision Maki

2004
Understanding NSAID-PPI-COX-2 interrelationships.
    Drugs of today (Barcelona, Spain : 1998), 2004, Volume: 40 Suppl A

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzimida

2004
Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users?
    Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cohort Studies; Helicobacter

2004
[Impact of Helicobacter pylori infection on the risk of gastro-duodenal ulcer in patients treated with nonsteroidal antiinflammatory drugs].
    Gastroenterologie clinique et biologique, 2004, Volume: 28 Spec No 3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infectio

2004
[Epidemiology of digestive complications associated with use of low-dose aspirin].
    Gastroenterologie clinique et biologique, 2004, Volume: 28 Spec No 3

    Topics: Aspirin; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Risk Facto

2004
Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chinese journal of digestive diseases, 2005, Volume: 6, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; He

2005
Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.
    World journal of gastroenterology, 2005, Jul-07, Volume: 11, Issue:25

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Diseases; Helicobacter Infections

2005
Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications.
    Postgraduate medicine, 2005, Volume: 117, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Dyspepsia; Gastrointest

2005
[Relationship between NSAIDs and H. pylori in peptic ulcer diseases--is the eradication of H. pylori recommended in NSAIDs ulcer?].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Helicobacter Infections;

2005
Peptic ulcer disease today.
    Nature clinical practice. Gastroenterology & hepatology, 2006, Volume: 3, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxy

2006
Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression.
    Alimentary pharmacology & therapeutics, 2006, Mar-15, Volume: 23, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Endoscopy, Gastrointestinal; Gastrins; Gastroesoph

2006
Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
    World journal of gastroenterology, 2006, Jun-28, Volume: 12, Issue:24

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiova

2006
NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Chinese journal of digestive diseases, 2006, Volume: 7, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2 Inhibitors; Drug Combinations; Dy

2006
Management of high-risk patients on non-steroidal anti-inflammatory drugs or aspirin.
    Drugs, 2006, Volume: 66 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Gastrointestinal Diseases

2006
[Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].
    Der Internist, 2006, Volume: 47, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Gastritis; Gastrointest

2006
Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Current medical research and opinion, 2007, Volume: 23, Issue:1

    Topics: Anti-Ulcer Agents; Aspirin; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori;

2007
Iron deficiency in childhood and adolescence: retrospective review.
    Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:3

    Topics: Adolescent; Anemia, Iron-Deficiency; Animals; Aspirin; Cattle; Celiac Disease; Child; Child, Prescho

2006
Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
    Reviews in cardiovascular medicine, 2005, Volume: 6 Suppl 4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiology; Cardiovascular Dise

2005
Strategies to reduce the GI risks of antiplatelet therapy.
    Reviews in cardiovascular medicine, 2005, Volume: 6 Suppl 4

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiova

2005
Maintenance therapy for peptic ulcer--who needs it?
    Gastroenterologia Japonica, 1993, Volume: 28 Suppl 5

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Helicobacter Infections; Heli

1993
[Digestive complications of aspirin].
    La Revue de medecine interne, 2000, Volume: 21 Suppl 1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Digestive System;

2000
Non-steroidal anti-inflammatory drugs and gastrointestinal damage-problems and solutions.
    Postgraduate medical journal, 2001, Volume: 77, Issue:904

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase Inhibitors

2001
Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. Introduction.
    The American journal of medicine, 2001, Jan-08, Volume: 110, Issue:1A

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase 2; Cyclooxygenas

2001
Management of nonsteroidal anti-inflammatory drug-related peptic ulcer bleeding.
    The American journal of medicine, 2001, Jan-08, Volume: 110, Issue:1A

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Butanone

2001
Questions regarding future research on aspirin and the gastrointestinal tract.
    The American journal of medicine, 2001, Jan-08, Volume: 110, Issue:1A

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Delayed-Action

2001
Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement.
    The American journal of medicine, 2001, Jan-08, Volume: 110, Issue:1A

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Cyclooxygenase I

2001
Epidemiology of NSAID-related gastroduodenal mucosal injury.
    Best practice & research. Clinical gastroenterology, 2001, Volume: 15, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc

2001
Gastrointestinal safety of COX-2 specific inhibitors.
    Gastroenterology clinics of North America, 2001, Volume: 30, Issue:4

    Topics: Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygena

2001

Trials

23 trials available for aspirin and Infections, Helicobacter

ArticleYear
Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.
    Lancet (London, England), 2022, 11-05, Volume: 400, Issue:10363

    Topics: Aged; Anti-Bacterial Agents; Aspirin; Clarithromycin; Drug Therapy, Combination; Helicobacter; Helic

2022
In older patients receiving aspirin,
    Annals of internal medicine, 2023, Volume: 176, Issue:4

    Topics: Aged; Aspirin; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Peptic Ulcer;

2023
Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.
    The West Indian medical journal, 2013, Volume: 62, Issue:2

    Topics: Angiography; Aspirin; Breath Tests; Carotid Arteries; Carotid Stenosis; Clopidogrel; Drug Interactio

2013
Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:8

    Topics: Adult; Anti-Ulcer Agents; Asian People; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy

2014
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Lancet (London, England), 2009, Jul-11, Volume: 374, Issue:9684

    Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Double-Blind Me

2009
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
    Gastroenterology, 2010, Volume: 138, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-

2010
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
    Gastroenterology, 2010, Volume: 138, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-

2010
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
    Gastroenterology, 2010, Volume: 138, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-

2010
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
    Gastroenterology, 2010, Volume: 138, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-

2010
Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers.
    The American journal of gastroenterology, 2012, Volume: 107, Issue:7

    Topics: Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Chi-Square Distribution; Drug Therapy, Co

2012
Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Journal of gastroenterology and hepatology, 2004, Volume: 19, Issue:7

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer

2004
Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ben

2004
Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
    European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agent

2005
Effect of high-dose aspirin on Helicobacter pylori eradication.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:4

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromyc

2005
Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 2006, Apr-15, Volume: 23, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies

2006
Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer A

2007
Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006, Volume: 57 Suppl 5

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Aspirin; Cells, Cultured;

2006
Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:9

    Topics: Adaptation, Physiological; Adult; Aspirin; Cell Division; DNA; Female; Gastric Mucosa; Gastroscopy;

1998
Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:2

    Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Gastrointestinal

2000
Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans.
    American journal of physiology. Gastrointestinal and liver physiology, 2000, Volume: 279, Issue:5

    Topics: Adolescent; Adult; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Fem

2000
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    The New England journal of medicine, 2001, Mar-29, Volume: 344, Issue:13

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Drug The

2001
Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
    Microscopy research and technique, 2001, Jun-01, Volume: 53, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agent

2001
Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
    The American journal of gastroenterology, 2001, Volume: 96, Issue:6

    Topics: Adolescent; Adult; Antibodies, Bacterial; Aspirin; Blood Platelets; Cyclooxygenase 1; Double-Blind M

2001
[Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid afte
    Arzneimittel-Forschung, 2002, Volume: 52, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Drug Combinations; Endoscopy; F

2002
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
    The New England journal of medicine, 2002, Jun-27, Volume: 346, Issue:26

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer A

2002
Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.
    The American journal of gastroenterology, 1991, Volume: 86, Issue:6

    Topics: Adult; Aspirin; Duodenal Ulcer; Duodenum; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Helic

1991

Other Studies

160 other studies available for aspirin and Infections, Helicobacter

ArticleYear
Accumulation of Deleterious Effects in Gastric Epithelial Cells and Vascular Endothelial Cells In Vitro in the Milieu of
    International journal of molecular sciences, 2022, Jun-06, Volume: 23, Issue:11

    Topics: Antigens, Bacterial; Aspirin; Endothelial Cells; Epithelial Cells; Gastric Mucosa; Helicobacter Infe

2022
Aspirin and Helicobacter pylori interaction.
    Lancet (London, England), 2022, 11-05, Volume: 400, Issue:10363

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma

2022
Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin.
    Gastroenterology, 2023, Volume: 164, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicoba

2023
Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin.
    Gastroenterology, 2023, Volume: 164, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicoba

2023
Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin.
    Gastroenterology, 2023, Volume: 164, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicoba

2023
Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin.
    Gastroenterology, 2023, Volume: 164, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicoba

2023
Helicobacter pylori eradication as a gastroprotective strategy in elderly aspirin-treated subjects: established facts and unanswered questions.
    European heart journal, 2023, 03-01, Volume: 44, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infectio

2023
Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months.
    Helicobacter, 2023, Volume: 28, Issue:4

    Topics: Anti-Bacterial Agents; Aspirin; Coronary Disease; Female; Follow-Up Studies; Helicobacter Infections

2023
Helicobacter pylori eradication and aspirin: a puzzle yet to be solved.
    Lancet (London, England), 2023, 04-15, Volume: 401, Issue:10384

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; He

2023
Helicobacter pylori eradication and aspirin: a puzzle yet to be solved - Author's reply.
    Lancet (London, England), 2023, 04-15, Volume: 401, Issue:10384

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; He

2023
Should people taking low-dose aspirin have
    Drug and therapeutics bulletin, 2023, Volume: 61, Issue:8

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination;

2023
Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
    British journal of cancer, 2019, Volume: 121, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus; Fe

2019
Commentary: cardioprotective aspirin and gastroduodenal ulcers.
    Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:1

    Topics: Aspirin; Helicobacter Infections; Humans; Incidence; Peptic Ulcer; Prevalence

2020
Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment.
    Scandinavian journal of gastroenterology, 2020, Volume: 55, Issue:2

    Topics: Aged; Aged, 80 and over; Aspirin; Female; Gastroscopy; Helicobacter Infections; Histamine H2 Antagon

2020
Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs.
    PloS one, 2021, Volume: 16, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cell Line; Female; Ga

2021
Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
    United European gastroenterology journal, 2021, Volume: 9, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagula

2021
Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Duct Neoplasms; Bile

2021
Gastric Ulcer Hemorrhage - a Potential Life-Threatening Complication of Intragastric Balloon Treatment of Obesity.
    Obesity facts, 2017, Volume: 10, Issue:2

    Topics: Adult; Aspirin; Bariatric Surgery; Gastric Balloon; Gastrointestinal Hemorrhage; Helicobacter Infect

2017
Continuing use of antithrombotic medications for patients with bleeding gastroduodenal ulcer requiring endoscopic hemostasis: a case-control study.
    Scandinavian journal of gastroenterology, 2017, Volume: 52, Issue:9

    Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Duodenal Ulcer; Duodenum; Female; Fibrinolyt

2017
The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy.
    European journal of internal medicine, 2017, Volume: 44

    Topics: Aged; Anemia; Aspirin; Atrophy; Causality; Endoscopy, Gastrointestinal; Female; Gastrointestinal Dis

2017
High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury.
    Digestive diseases (Basel, Switzerland), 2018, Volume: 36, Issue:1

    Topics: Aged; Area Under Curve; Aspirin; Duodenum; Female; Gastrins; Helicobacter Infections; Helicobacter p

2018
Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer.
    Scientific reports, 2017, 10-17, Volume: 7, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; CpG

2017
Uninvestigated dyspepsia and associated factors of patients with gastrointestinal disorders in Dessie Referral Hospital, Northeast Ethiopia.
    BMC gastroenterology, 2018, Jan-18, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Sectional Studies;

2018
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study.
    Journal of the National Cancer Institute, 2018, 07-01, Volume: 110, Issue:7

    Topics: Adult; Aged; Aspirin; Chemoprevention; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Fe

2018
The Value of Helicobacter Eradication in Long-term Aspirin Users.
    Journal of the National Cancer Institute, 2018, 07-01, Volume: 110, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter; Helicobacter Infections; Helicobacte

2018
Gastroduodenal ulcer bleeding in elderly patients on low dose aspirin therapy.
    World journal of gastroenterology, 2018, Sep-14, Volume: 24, Issue:34

    Topics: Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cerebrovascu

2018
Low dose aspirin, H. pylori infection, and the risk of upper gastrointestinal bleeding.
    The Medical journal of Australia, 2018, 09-01, Volume: 209, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma

2018
Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2019, Volume: 118, Issue:5

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Comorbidity; Cyclooxygenase

2019
Statins and gastroduodenal endoscopic lesions: A case-control study.
    Medicine, 2018, Volume: 97, Issue:50

    Topics: Adult; Aged; Aspirin; Case-Control Studies; Chi-Square Distribution; Comorbidity; Endoscopy; Female;

2018
Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for
    Gut, 2020, Volume: 69, Issue:3

    Topics: Adult; Aged; Aspirin; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pyl

2020
Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
    Journal of gastroenterology, 2014, Volume: 49, Issue:5

    Topics: Aged; Aspirin; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Gastrointestinal Diseases;

2014
[HP eradication prevents recurrent hemorrhages caused by acetylsalicylic acid].
    MMW Fortschritte der Medizin, 2013, Jun-27, Volume: 155, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cohort Studies; Drug Therapy, C

2013
Relationship between continuous use of low-dose enteric-coated aspirin and gastrointestinal injuries in patients with gastrointestinal hemorrhage.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2013, Volume: 24, Issue:2

    Topics: Aspirin; Case-Control Studies; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastrointestinal

2013
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2013, Volume: 62, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal

2013
Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake.
    Alimentary pharmacology & therapeutics, 2013, Volume: 38, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breath

2013
Testing for the 'ulcer bug' makes daily aspirin safer.
    Harvard men's health watch, 2013, Volume: 17, Issue:11

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; He

2013
Low-dose aspirin and comorbidities are significantly related to bleeding peptic ulcers in elderly patients compared with nonelderly patients in Japan.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:5

    Topics: Adolescent; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents,

2014
Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects.
    Journal of gastroenterology, 2015, Volume: 50, Issue:3

    Topics: Aged; Aged, 80 and over; Antibodies, Bacterial; Aspirin; Biomarkers; Drug Administration Schedule; F

2015
Risk factors associated with uncomplicated peptic ulcer and changes in medication use after diagnosis.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studi

2014
Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
    Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Antihyper

2015
Regular aspirin use and stomach cancer risk in China.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; Case-Control Studies; China; Fema

2015
Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.
    The American journal of gastroenterology, 2015, Volume: 110, Issue:5

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Female; Helicob

2015
Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding.
    World journal of gastroenterology, 2015, Jul-28, Volume: 21, Issue:28

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Breath Tests; Endoscopy, Gast

2015
Study of Clinical and Genetic Risk Factors for Aspirin-induced Gastric Mucosal Injury.
    Chinese medical journal, 2016, Jan-20, Volume: 129, Issue:2

    Topics: Aged; Aspirin; Female; Gastric Mucosa; Genotype; Helicobacter Infections; Humans; Male; Middle Aged;

2016
Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators.
    The New Zealand medical journal, 2016, Mar-11, Volume: 129, Issue:1431

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Clinical Decision-M

2016
Effects of low-dose aspirin in subjects with dyslipidemia.
    Lipids in health and disease, 2016, Jun-16, Volume: 15

    Topics: Adult; Aspirin; C-Reactive Protein; Cholesterol, LDL; Convalescence; Coronary Angiography; Coronary

2016
Etiological Factors in Urgent Gastroduodenal Ulcer.
    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2015, Volume: 36, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroid

2015
Short-term/low-dose aspirin-induced duodenal erosions are not dependent on Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels.
    Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Dinoprostone; Du

2008
Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood.
    Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:10

    Topics: Adult; alpha 1-Antitrypsin; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Enzyme-Linked Immunoso

2008
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
    Journal of the American College of Cardiology, 2008, Oct-28, Volume: 52, Issue:18

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combina

2008
[Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Ugeskrift for laeger, 2009, Jan-19, Volume: 171, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Duodenal Ulcer; Femal

2009
Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antigens, CD; Aspirin; Cadherins;

2010
Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin.
    Journal of gastroenterology, 2009, Volume: 44, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Agents; En

2009
Guidelines for prevention of NSAID-related ulcer complications.
    The American journal of gastroenterology, 2009, Volume: 104, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticoagulants; Aspirin; Cyclooxygenase

2009
Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.
    BMC gastroenterology, 2009, Apr-20, Volume: 9

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Dose-Response Relationshi

2009
Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy.
    Journal of gastroenterology, 2009, Volume: 44, Issue:9

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cerebrovascular Dis

2009
NSAIDs and aspirin: notorious or FAMOUS?
    Lancet (London, England), 2009, Jul-11, Volume: 374, Issue:9684

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase Inhibitors; Esop

2009
Gastroprotective strategy in aspirin users.
    Journal of the Chinese Medical Association : JCMA, 2009, Volume: 72, Issue:7

    Topics: Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hum

2009
[Treatment and prophylaxis of alimentary tract lesions caused by non-steroid anti-inflammatory drugs].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2009, Volume: 26, Issue:155

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Digestive System Diseases; Helicobacter Infections

2009
Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy.
    British journal of clinical pharmacology, 2009, Volume: 68, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Epidemiologic Methods; Female; Gastric Muco

2009
Predictors of gastroduodenal erosions in patients taking low-dose aspirin.
    Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Endoscopy; Femal

2010
[Guidelines of prevention and treatment for NSAID-related peptic ulcers].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2009, Volume: 54, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticoagulants; Aspirin; Cyclooxygenase

2009
Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breath Tests;

2010
[Pseudoneoplastic regeneration of the stomach. Histopathology and differential diagnosis].
    Der Pathologe, 2010, Volume: 31, Issue:3

    Topics: Aspirin; Carcinoma; Diagnosis, Differential; Gastritis; Helicobacter Infections; Humans; Intestinal

2010
Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:11

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biops

2010
[The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2010, Volume: 55, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aspirin; Child; Drug Therapy, Com

2010
Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study.
    Journal of gastroenterology and hepatology, 2010, Volume: 25 Suppl 1

    Topics: Aged; Aspirin; Cardiovascular Agents; Duodenal Ulcer; Endoscopy, Digestive System; Esophageal Neopla

2010
[Risk factors for development and recurrence of peptic ulcer disease].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2010, Volume: 56, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Endoscopy, Gastrointestinal; Female;

2010
[Significance of H. pylori eradication in treatment and prevention for low-dose aspirin induced gastric ulcer of elderly].
    Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:11

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori

2010
Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy.
    Journal of gastroenterology, 2011, Volume: 46, Issue:5

    Topics: Aged; Aspirin; Endoscopy, Gastrointestinal; Fibrinolytic Agents; Gastric Acid; Gastric Mucosa; Gastr

2011
[The effect of aspirin alone or aspirin plus additional antiplatelets therapy on upper gastrointestinal hemorrhage].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 57, Issue:4

    Topics: Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents;

2011
Low-dose aspirin delays gastric healing after Helicobacter pylori eradication.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:9

    Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Female; Gastric Mucosa; Gastritis; Gastrosco

2011
Does long-term aspirin use have any effect on Helicobacter pylori eradication?
    The American journal of the medical sciences, 2011, Volume: 342, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-

2011
A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2011, Volume: 22, Issue:3

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Comorbidity; Endoscopy, Gastrointestinal; Fe

2011
Anti-platelet therapy and managing ulcer risk.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Combined Modali

2012
New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:4

    Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Helic

2012
Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin.
    Journal of gastroenterology, 2012, Volume: 47, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Aspirin; Case

2012
Correlation between Helicobacter pylori infection and low-dose aspirin use on damage of the upper gastrointestinal tract.
    Journal of gastroenterology and hepatology, 2012, Volume: 27 Suppl 3

    Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chi-Square Distributio

2012
Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice.
    Best practice & research. Clinical gastroenterology, 2012, Volume: 26, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastric Acid; Gastrointestinal Diseases; Gastroint

2012
Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level.
    Journal of gastroenterology, 2012, Volume: 47, Issue:12

    Topics: Aged; Aspirin; Drug Administration Schedule; Female; Fibrinolytic Agents; Gastric Acid; Helicobacter

2012
The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
    Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Endoscopy; Endoscopy, Gas

2012
Commentary: changing aetiology of peptic ulcers.
    Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Helicobacter Infections; Helicobacter pylo

2012
Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2012, Volume: 23, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cyclooxygenase 2 Inhibitors;

2012
Letter: are idiopathic (non-NSAID, non-Helicobacter pylori) ulcers really increasing?
    Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Helicobacter Infections; Helicobacter pylo

2012
[Gastrointestinal bleeding associated with NSAIDs, antiplatelet therapy and anticoagulant agent].
    Gastroenterologia y hepatologia, 2012, Volume: 35 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Gastrointestinal Hemorrhage; Helic

2012
[Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori].
    Zeitschrift fur Gastroenterologie, 2012, Volume: 50, Issue:11

    Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Clopid

2012
Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2012, Volume: 111, Issue:12

    Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Endoscopy, Gastrointestinal; Female; Gastrointestinal

2012
Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users.
    Gastroenterology, 2013, Volume: 144, Issue:3

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Fibrinolytic Agents; Helicobacter In

2013
Can the diagnosis of NSAID-induced or Hp-associated gastric ulceration be predicted from histology?
    Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:9

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Comorbidity; Diagnosis, Differential

2002
Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:11

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Drug Administration

2002
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin.
    The New England journal of medicine, 2002, Nov-14, Volume: 347, Issue:20

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents;

2002
Correlation between erosive oesophageal and gastro-duodenal diseases. the influence of aspirin, simple analgesics, and Helicobacter pylori.
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:12

    Topics: Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Duode

2002
Low-dose aspirin: protection from the panacea.
    The American journal of gastroenterology, 2002, Volume: 97, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents;

2002
[A case for proton pump blocker... When cough comes from the stomach].
    MMW Fortschritte der Medizin, 2002, Nov-07, Volume: 144, Issue:45

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Age

2002
Effect of H. pylori infection on the expression of cyclooxygenase-2 in human gastric mucosa.
    Prostaglandins, leukotrienes, and essential fatty acids, 2003, Volume: 68, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Cyclooxygenase 2; Female; Gastric Mucosa; Helicobacter

2003
Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
    The New England journal of medicine, 2003, Jun-12, Volume: 348, Issue:24

    Topics: Aspirin; Cardiovascular Diseases; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter

2003
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study.
    Alimentary pharmacology & therapeutics, 2003, Jun-15, Volume: 17, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Barret

2003
Effect of Helicobacter pylori infection and low-dose aspirin use on iron stores in the elderly.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:9

    Topics: Aged; Aspirin; Female; Fibrinolytic Agents; Helicobacter Infections; Helicobacter pylori; Humans; Ir

2003
[Heartburn without esophagitis. Symptoms more important than the finding?].
    MMW Fortschritte der Medizin, 2003, Sep-25, Volume: 145, Issue:39

    Topics: Androstadienes; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ul

2003
Dyspeptic symptoms associated with Helicobacter pylori infection are influenced by strain and host specific factors.
    Alimentary pharmacology & therapeutics, 2004, Jan-15, Volume: 19, Issue:2

    Topics: Adult; Aged; Alcohol Drinking; Aspirin; Cohort Studies; Dyspepsia; Female; Helicobacter Infections;

2004
Helicobacter pylori infection and the risk of gastro-duodenal damage in symptomatic elderly chronic low-dose aspirin users: effect of antisecretory drugs.
    Age and ageing, 2004, Volume: 33, Issue:4

    Topics: Aged; Aspirin; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists;

2004
[Helicobacter pylori: changes of indications for eradication therapy].
    Deutsche medizinische Wochenschrift (1946), 2004, Sep-03, Volume: 129 Suppl 2

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Drug Therapy, Combination; Gastroesophageal Reflu

2004
Association of aspirin use with vitamin B12 deficiency (results of the BACH study).
    The American journal of cardiology, 2004, Oct-01, Volume: 94, Issue:7

    Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Viral; Aspirin; Biomarkers;

2004
Prevention of aspirin-induced gastroduodenal damage: H. pylori infection eradication versus proton pump inhibitors or both.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Aspirin; Dose-Response Relationship

2004
Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy.
    European journal of pharmacology, 2004, Dec-15, Volume: 506, Issue:2

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Aspirin; Blotting, Wester

2004
Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.
    Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breath Tests; Case-Control Studies; D

2005
The appropriate use of proton-pump inhibitor co-therapy with non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors.
    Alimentary pharmacology & therapeutics, 2005, Volume: 21 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Contraindications; Cyclooxygenase Inhibitors; Drug

2005
Definitions and classification of dyspepsia: pH, Helicobacter pylori, non-steroidal anti-inflammatory drugs--should we include gastro-oesophageal reflux disease?
    Alimentary pharmacology & therapeutics, 2005, Volume: 21 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dyspepsia; Gastroesophageal Reflux; Helicobacter I

2005
A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
    Alimentary pharmacology & therapeutics, 2005, Volume: 21 Suppl 2

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Endoscopy, Gastroi

2005
Protective role of heat shock protein 27 in gastric mucosal injury.
    The Journal of pathology, 2005, Volume: 207, Issue:2

    Topics: Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2;

2005
[Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2005, Volume: 6, Issue:10

    Topics: Age Factors; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer A

2005
Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
    Helicobacter, 2006, Volume: 11, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Duodenum;

2006
Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
    Alimentary pharmacology & therapeutics, 2006, Mar-01, Volume: 23, Issue:5

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Attitude of Health Personnel; Cardiot

2006
[Gastric protection and treatment with low-dose aspirin].
    Medicina clinica, 2006, Feb-18, Volume: 126, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal;

2006
Frequency of NSAID induced peptic ulcer disease.
    JPMA. The Journal of the Pakistan Medical Association, 2006, Volume: 56, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclof

2006
[Gastroenterology in family practice. Updates for your "stomach patient"].
    MMW Fortschritte der Medizin, 2006, Jun-01, Volume: 148, Issue:22

    Topics: Anti-Ulcer Agents; Aspirin; Clopidogrel; Dyspepsia; Esophagitis, Peptic; Family Practice; Heartburn;

2006
H pylori infection and other risk factors associated with peptic ulcers in Turkish patients: a retrospective study.
    World journal of gastroenterology, 2007, Jun-21, Volume: 13, Issue:23

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ethano

2007
Gastroduodenal lesions in coronary artery disease patients. Frequency, endoscopic characteristics and risk factors.
    Saudi medical journal, 2007, Volume: 28, Issue:7

    Topics: Aspirin; Coronary Disease; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middl

2007
The value of a stretch in the "common era".
    Gastrointestinal endoscopy, 2007, Volume: 66, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Catheterization; Combined Modal

2007
Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
    Gastrointestinal endoscopy, 2007, Volume: 66, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin;

2007
[Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschritte der Medizin, 2007, Oct-25, Volume: 149, Issue:43

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspi

2007
[Family practice highlights of stomach, liver and intestinal reference points. Your arsenal against abdominal problems].
    MMW Fortschritte der Medizin, 2007, Nov-29, Volume: 149, Issue:48

    Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Barrett Esophagus; Family Practi

2007
Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils.
    Helicobacter, 2008, Volume: 13, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Aspirin; Choristoma; Dinoprostone; Epithelial Cells; G

2008
A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
    Clinical therapeutics, 2008, Volume: 30, Issue:1

    Topics: Aged; Alcohol Drinking; Aspirin; Case-Control Studies; Female; Gastrointestinal Hemorrhage; Gene Fre

2008
Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:5

    Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Sectional Studies; Dyspepsia

2008
Risk factors associated with refractory peptic ulcers.
    Gastroenterology, 1995, Volume: 109, Issue:4

    Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Female; Gastric

1995
Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori.
    Digestive diseases and sciences, 1994, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Alcohol Drinking; Analgesics; Antibodies, Bacterial; Aspirin; Blood Donors; Colon

1994
Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
    The American journal of medicine, 1993, Volume: 94, Issue:4

    Topics: Adult; Age Factors; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Fema

1993
Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose.
    Gut, 1996, Volume: 39, Issue:2

    Topics: Adult; Aspirin; Biomarkers; Chromatography, High Pressure Liquid; Female; Gastric Mucosa; Gastrointe

1996
Evidence of aspirin use in both upper and lower gastrointestinal perforation.
    Gastroenterology, 1997, Volume: 112, Issue:3

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Helicobacter Infections; Helicobacte

1997
Helicobacter pylori infection status in relation to antibiotic and non-steroidal prescribing in patients on maintenance treatment for chronic duodenal ulcer.
    European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Chroni

1997
Could there be an aspirin good to your stomach?
    The American journal of gastroenterology, 1997, Volume: 92, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma

1997
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1997, Volume: 48, Issue:3

    Topics: Adaptation, Physiological; Adult; Aspirin; DNA; Female; Gastric Mucosa; Gastrointestinal Hemorrhage;

1997
Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.
    Gut, 1997, Volume: 41, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Female; Helicobacter I

1997
Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1997, Volume: 48 Suppl 4

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Dru

1997
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.
    Gastroenterology, 1998, Volume: 114, Issue:2

    Topics: Adaptation, Physiological; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dino

1998
Aspirin-induced gastritis, like Helicobacter pylori-induced gastritis disinhibits acid secretion in humans: relation to cytokine expression.
    Scandinavian journal of gastroenterology, 1998, Volume: 33, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cytokines; Female; Gastric Acid; Gastric Di

1998
Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection.
    Archives of internal medicine, 1998, Jul-13, Volume: 158, Issue:13

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Donors; Dyspepsia; Female; Helicobact

1998
Effect of cytokines on acid secretion and gastrin secretion in Helicobacter pylori infection and aspirin-induced gastritis.
    Scandinavian journal of gastroenterology, 1998, Volume: 33, Issue:11

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cytokines; Gastric Acid; Gastrins; Gastri

1998
Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia.
    International journal of cancer, 1999, Aug-12, Volume: 82, Issue:4

    Topics: Adenocarcinoma; Aged; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma,

1999
FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    European journal of pharmacology, 1999, Aug-13, Volume: 378, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atrial Function; D

1999
H. pylori and risk of ulcer bleeding among users of NSAIDS.
    Gastroenterology, 2000, Volume: 118, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infectio

2000
The effects of aspirin on antioxidant defences of cultured rat gastric mucosal cells.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14 Suppl 1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Cells, Cultured; Dose-Respo

2000
Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.
    Cancer research, 2000, Nov-15, Volume: 60, Issue:22

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Ant

2000
Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.
    The American journal of medicine, 2001, Jan-08, Volume: 110, Issue:1A

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents;

2001
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.
    British journal of cancer, 2001, Apr-06, Volume: 84, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies;

2001
Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2001, Volume: 52, Issue:1

    Topics: Adaptation, Physiological; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Blotti

2001
Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:7

    Topics: Aspirin; Calcium Channel Blockers; Deglutition Disorders; Dyspepsia; Fibrinolytic Agents; Flatulence

2001
Preventing upper gastrointestinal bleeding in patients with Helicobacter pylori infection.
    The New England journal of medicine, 2001, Jul-05, Volume: 345, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastrointestinal Hemorrhage; He

2001
Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Scandinavian journal of gastroenterology, 2001, Volume: 36, Issue:8

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dyspepsia; Endoscopy, Digestive System; Fema

2001
The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathy.
    The American journal of managed care, 2001, Volume: 7, Issue:12 Suppl

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cost of Illness; Cyclooxy

2001
Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin.
    Journal of endotoxin research, 2001, Volume: 7, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Disease Models, Animal; Gastri

2001
Elimination of Helicobacter pylori or acid in high-risk users of aspirin or nonsteroidal medications: final answer?
    Gastroenterology, 2002, Volume: 122, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastric Acid; Gastrointestinal Hemorrhage; Helicob

2002
[Long-term prophylaxis with omeprazol is superior to eradication therapy in H. pylori-positive NSAIDs taking patients].
    Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Helicobacter Inf

2002
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Aspirin; Bacterial Protei

2002
Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Female; Gastrointestin

2002
Aspirin injury and H pylori.
    Gut, 2002, Volume: 50, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gerbillinae; Helicobacter Infections; Hel

2002
Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils.
    Gut, 2002, Volume: 50, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemotactic Factors; Gastric Mucosa; Gerb

2002
Role of elastase and active oxygen species in gastric mucosal injury induced by aspirin administration in Helicobacter pylori-infected Mongolian gerbils.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16 Suppl 2

    Topics: Animals; Aspirin; Catalase; Free Radical Scavengers; Gastric Mucosa; Gerbillinae; Glycine; Helicobac

2002
Helicobacter pylori and acetylsalicylic acid synergistically accelerate apoptosis via Fas antigen pathway in rabbit gastric epithelial cells.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Apoptosis; Aspirin; Bacterial

2002
[Low-dose of aspirin, gastroprotection and Helicobacter pylori erradication].
    Revista espanola de cardiologia, 2002, Volume: 55, Issue:5

    Topics: Aged; Aspirin; Helicobacter Infections; Helicobacter pylori; Humans; Platelet Aggregation Inhibitors

2002
Gastric changes in coronary-operated patients with low-dose aspirin.
    Scandinavian journal of gastroenterology, 1992, Volume: 27, Issue:11

    Topics: Adult; Aged; Aspirin; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Fe

1992
Helicobacter pylori-negative duodenal ulcer.
    The American journal of medicine, 1991, Volume: 91, Issue:1

    Topics: Aspirin; Chronic Disease; Duodenal Ulcer; Duodenoscopy; Female; Gastritis; Helicobacter Infections;

1991